U.S. Metals and Mining Stock News

Fiserv (FISV) is back in the spotlight after a wave of cautious analyst updates and investor letters questioning its turnaround story, even as fresh product integrations and long term growth plans continue moving forward. See our latest analysis for Fiserv. The latest integration wins and cautious analyst commentary are playing out against a sharp reset in expectations. Fiserv’s 30 day share price return of 8.75% offers a tentative bounce after a year to date share price decline of 66.52% and...

Box (BOX) has slipped over the past month and quarter, even as its long term performance remains solid. That pullback has investors asking whether the current valuation fairly reflects its growth profile. See our latest analysis for Box. Over the past year, Box’s share price return has drifted lower, with the recent 7 day and 30 day share price returns both negative, even though the 5 year total shareholder return remains meaningfully positive. This suggests momentum has cooled while the long...

Rocket Lab (RKLB) just checked two big boxes for investors, qualifying its world first reusable Neutron fairing and successfully flying JAXA’s dedicated RAISE And Shine mission, together strengthening its case for higher margin, repeat business. See our latest analysis for Rocket Lab. The latest pullback, with a roughly 9.9% one day share price return decline after the JAXA success, looks more like profit taking than a change in thesis. This is especially the case given Rocket Lab’s triple...

In early December 2025, Las Vegas Sands drew attention as Chairman and CEO Robert G. Goldstein sold about US$26.6 million of stock after exercising options, while the company also presented at Macquarie’s Asia Conference 2025 in New York. Analyst sentiment turned more constructive as Goldman Sachs upgraded Las Vegas Sands to Buy, reflecting growing confidence in the company’s Singapore and Macau-focused operations despite recent insider selling. With Goldman Sachs’ upgrade highlighting...

Earlier this week, CNA Financial moved after the Federal Reserve cut its benchmark interest rate by 25 basis points to a range of 3.5%–3.75%, with Chair Jerome Powell’s comments easing concerns about tighter policy ahead. The reaction underscored how closely investors link CNA Financial’s prospects to shifts in monetary policy, given the company’s reliance on investment income and broader market conditions. We’ll now examine how the Fed’s interest rate cut, and its effect on expectations for...

Stock performance snapshot Novo Nordisk (NYSE:NVO) shares have quietly rebounded about 8% over the past week, trimming some of this year’s heavy slide. As a result, some investors are asking whether the pullback has finally gone too far. See our latest analysis for Novo Nordisk. Even after this latest bounce, Novo Nordisk’s 90 day share price return of negative 11.9 percent and one year total shareholder return of negative 52.5 percent show that momentum has been fading, despite ongoing...

Vaxcyte (PCVX) just crossed a major clinical milestone by dosing the first participants in its OPUS Phase 3 trial for VAX-31, a next generation pneumococcal vaccine candidate aligned with FDA expectations. See our latest analysis for Vaxcyte. The OPUS Phase 3 start comes after a volatile stretch, with the latest share price at $44.34 and a roughly 44% 3 month share price return contrasting with a much weaker 1 year total shareholder return. This suggests near term momentum is rebuilding as...

CenterPoint Energy’s board previously declared a regular quarterly cash dividend of US$0.23 per share, payable on March 12, 2026, to shareholders of record on February 19, 2026, while the company also joined Palantir’s new Chain Reaction AI infrastructure platform as a founding partner alongside NVIDIA. This combination of a higher cash return to shareholders and early involvement in AI-driven power infrastructure software highlights how CenterPoint is balancing traditional utility income...

On December 3, 2025, American Financial Group increased its equity buyback authorization by 5,000,000 shares to a total of 57,188,938 shares and extended the program through December 31, 2030. This larger and longer buyback plan highlights management’s capital-return priorities and may gradually reshape the company’s ownership base over time. We’ll now examine how AFG’s enlarged, longer-dated buyback authorization could influence its existing investment narrative around earnings growth and...

fuboTV (FUBO) has been grinding lower recently, with the stock down around 29% over the past month and about 40% in the past 3 months, despite revenue growing roughly 30% annually. See our latest analysis for fuboTV. Zooming out, that recent slide comes after a sharp rally, with the year to date share price return still strong and the one year total shareholder return comfortably positive. This suggests momentum has cooled rather than completely reversed as investors reassess execution risk...

Wondering if Hilton Worldwide Holdings is still a smart buy after its huge run, or if the easy money has already been made? You are not alone. The stock has climbed 5.9% over the last week, 6.0% over the past month and is now up 16.6% year to date, adding to an already impressive 178.3% gain over five years. Part of this strength reflects steady optimism around global travel demand and Hilton's capital-light, fee-based model that investors increasingly see as structurally attractive. At the...

Integral Ad Science Holding (IAS) has been quietly grinding higher, with shares up about 22% over the past 3 months as investors reappraise its role in ad verification and connected TV. See our latest analysis for Integral Ad Science Holding. That recent 22% 3 month share price return has helped repair some of the damage from a softer year to date and slightly negative 1 year total shareholder return, suggesting momentum is quietly rebuilding as investors reassess growth and risk. If IAS has...

Wondering if Enphase Energy is a beaten down gem or a value trap at today’s price? This article will walk you through what the numbers are really saying about the stock. The share price has slipped 0.6% over the last week, bounced 9.4% over the past month, but is still down a steep 56.0% year to date and 57.3% over the last year, with even deeper losses over 3 and 5 years. Those swings have come as investors reassess solar and clean energy names more broadly, with shifting sentiment around...

V.F (VFC) has been quietly climbing, with the stock up roughly 29% over the past month and 31% in the past 3 months, even as its longer term returns remain weak. See our latest analysis for V.F. Even after this short term rally, with the share price at $19.27, V.F still has a negative year to date share price return and a deeply negative five year total shareholder return. As a result, the recent momentum looks more like an early sentiment shift than a full comeback. If V.F’s rebound has you...

In early December 2025, investor law firm Schall Law Firm announced an investigation into Nutex Health over potential securities law violations linked to a short-seller report alleging improper billing practices and an undisclosed ‘mystery consultant’ relationship. This scrutiny adds legal and governance risk to Nutex Health’s story at a time when its business model already relies heavily on complex reimbursement and arbitration processes. We’ll now examine how the securities investigation...

If you have been wondering whether Constellation Energy is still worth buying after its huge run, you are not alone. This breakdown will help you decide if the current price still stacks up to its fundamentals. The stock has slipped about 0.6% over the last week but is still up 5.5% over the past month, 47.2% year to date, and 53.3% over the last year, with a 318.0% gain over three years reshaping expectations around its growth and risk profile. Investors have been reacting to Constellation...

Recent performance and context Nasdaq (NDAQ) has been quietly grinding higher, with the stock up about 7% over the past month and 20% year to date, even as short term daily moves remain relatively modest. See our latest analysis for Nasdaq. That steady 20% year to date share price return, alongside a robust 5 year total shareholder return of around 130%, suggests momentum is building again as investors lean back into Nasdaq’s long term growth and data platform story. If Nasdaq’s move has you...

Wondering if Adobe is a bargain or a trap at today’s price? You are not alone, especially with so much noise around big tech valuations right now. Over the last week the stock has inched up about 2.0%, and it is up roughly 6.1% over the past month, but shares are still down around 20.4% year to date and 22.9% over the last year, leaving many investors questioning whether the pullback has gone too far. Recent headlines have focused on Adobe’s aggressive push into AI powered creative tools and...

Recent performance and what is driving interest Fidelity National Financial (FNF) has been grinding higher, with the stock up about 2% over the past week and modestly positive over the past month, helped by steady revenue and earnings growth. See our latest analysis for Fidelity National Financial. Zooming out, Fidelity National Financial’s share price has edged higher this year. That steady climb, backed by improving earnings, suggests sentiment is cautiously turning more optimistic even...

Earlier in December 2025, The Home Depot reaffirmed its 2025 guidance, issued cautious but positive 2026 targets, launched a creator-focused marketing portal to bolster digital engagement, and expanded same-day delivery in Canada through an Instacart partnership covering more than 175 stores. Together with a recent Federal Reserve rate cut that commentators argue could support home improvement demand, these moves highlight how Home Depot is trying to deepen customer reach across both...

Fortune Brands Innovations, Inc. ( NYSE:FBIN ) will increase its dividend from last year's comparable payment on the...

Caleres, Inc. ( NYSE:CAL ) will pay a dividend of $0.07 on the 9th of January. Based on this payment, the dividend...

Key Insights Given the large stake in the stock by institutions, Digimarc's stock price might be vulnerable to their...

Roivant Sciences (ROIV) just tightened the roadmap on several key assets, updating investors on accelerated timelines for brepocitinib, steady mosliciguat progress, and clearer milestones in its high profile mRNA patent battles. See our latest analysis for Roivant Sciences. Those pipeline accelerations seem to be resonating with investors, with Roivant’s share price at $21.9 after an 81.29 percent year to date share price return and a 208.89 percent three year total shareholder return,...